Quantitative flow ratio versus fractional flow reserve for coronary revascularisation guidance (FAVOR III Europe): a multicentre, randomised, non-inferiority trial.

Autor: Andersen BK; Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark., Sejr-Hansen M; Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark., Maillard L; GCS ES Axium Rambot, Clinique Axium, Aix-en-Provence, France., Campo G; Cardiology Unit, Azienda Ospedaliera Universitaria di Ferrara, Ferrara, Italy., Råmunddal T; Department of Cardiology, Sahlgrenska University Hospital, Göteborg, Sweden., Stähli BE; Department of Cardiology, University Heart Center, University Hospital Zürich, Zürich, Switzerland., Guiducci V; Cardiology Unit, Azienda USL-IRCCS Reggio Emilia, Reggio Emilia, Italy., Serafino LD; Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy., Escaned J; Hospital Clinico San Carlos IDISSC, Complutense University of Madrid, Madrid, Spain; Centro de Investigación Biomédica En Red - Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain., Santos IA; Hospital Clinico Universitario de Valladolid, Valladolid, Spain., López-Palop R; Hospital Universitario Virgen de la Arrixaca, Murcia, Spain., Landmesser U; Department of Cardiology, Angiology and Intensive Care Medizin, Deutsches Herzzentrum Charité, Charité-Universitätsmedizin Berlin, Berlin, Germany; Deutsches Zentrum für Herz-Kreislaufforschung (DZHK), Partner Site Berlin, Berlin, Germany., Dieu RS; Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark., Mejía-Rentería H; Hospital Clinico San Carlos IDISSC, Complutense University of Madrid, Madrid, Spain., Koltowski L; 1st Department of Cardiology, Medical University of Warsaw, Warsaw, Poland., Žiubrytė G; Department of Cardiology, Hospital of Lithuanian University of Health Sciences Kaunas Clinics, Kaunas, Lithuania; Institute of Cardiology, Lithuanian University of Health Sciences, Kaunas, Lithuania., Cetran L; Hopital Haut-Leveque, Pessac, Bordeaux, France., Adjedj J; Institut Arnault Tzanck, Nice, France., Abdelwahed YS; Department of Cardiology, Angiology and Intensive Care Medizin, Deutsches Herzzentrum Charité, Charité-Universitätsmedizin Berlin, Berlin, Germany; Deutsches Zentrum für Herz-Kreislaufforschung (DZHK), Partner Site Berlin, Berlin, Germany., Liu T; Department of Cardiology, Hagaziekenhuis, The Hague, Netherlands., Mogensen LJH; Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark., Eftekhari A; Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark., Westra J; Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark., Lenk K; Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Leipzig, Germany., Casella G; Cardiology Unit Ospedale Maggiore, AUSL Bologna, Bologna, Italy., Belle EV; INSERM U1011 and Department of Interventional Cardiology, Lille University, Lille, France., Biscaglia S; Cardiology Unit, Azienda Ospedaliera Universitaria di Ferrara, Ferrara, Italy., Olsen NT; Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte, Gentofte, Denmark., Knaapen P; VU University Medical Center, Amsterdam, Netherlands., Kochman J; 1st Department of Cardiology, Medical University of Warsaw, Warsaw, Poland., Santos RC; Hospital Universitario A Coruña, Coruña, Spain., Scarsini R; Division of Cardiology, Department of Medicine, University of Verona, Verona, Italy., Christiansen EH; Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark., Holm NR; Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark. Electronic address: niels.holm@clin.au.dk.

Publikováno v: Lancet (London, England) [Lancet] 2024 Nov 09; Vol. 404 (10465), pp. 1835-1846. Date of Electronic Publication: 2024 Oct 30.

Inotropes and mortality in patients with cardiogenic shock: an instrumental variable analysis from the SWEDEHEART registry.

Autor: Petursson P; Department of Cardiology, Sahlgrenska University Hospital, Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg, Bruna stråket 16, 41345 Gothenburg, Sweden., Gudmundsson T; Department of Cardiology, Sahlgrenska University Hospital, Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg, Bruna stråket 16, 41345 Gothenburg, Sweden., Råmunddal T; Department of Cardiology, Sahlgrenska University Hospital, Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg, Bruna stråket 16, 41345 Gothenburg, Sweden., Angerås O; Department of Cardiology, Sahlgrenska University Hospital, Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg, Bruna stråket 16, 41345 Gothenburg, Sweden., Rawshani A; Department of Cardiology, Sahlgrenska University Hospital, Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg, Bruna stråket 16, 41345 Gothenburg, Sweden., Mohammad MA; Department of Cardiology, Sahlgrenska University Hospital, Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg, Bruna stråket 16, 41345 Gothenburg, Sweden., Persson J; Department of Cardiology, Sahlgrenska University Hospital, Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg, Bruna stråket 16, 41345 Gothenburg, Sweden., Alfredsson J; Department of Cardiology, Sahlgrenska University Hospital, Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg, Bruna stråket 16, 41345 Gothenburg, Sweden., Hofmann R; Department of Cardiology, Sahlgrenska University Hospital, Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg, Bruna stråket 16, 41345 Gothenburg, Sweden., Jernberg T; Department of Cardiology, Sahlgrenska University Hospital, Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg, Bruna stråket 16, 41345 Gothenburg, Sweden., Fröbert O; Department of Cardiology, Sahlgrenska University Hospital, Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg, Bruna stråket 16, 41345 Gothenburg, Sweden., Erlinge D; Department of Cardiology, Sahlgrenska University Hospital, Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg, Bruna stråket 16, 41345 Gothenburg, Sweden., Redfors B; Department of Cardiology, Sahlgrenska University Hospital, Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg, Bruna stråket 16, 41345 Gothenburg, Sweden., Omerovic E; Department of Cardiology, Sahlgrenska University Hospital, Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg, Bruna stråket 16, 41345 Gothenburg, Sweden.

Publikováno v: European heart journal. Cardiovascular pharmacotherapy [Eur Heart J Cardiovasc Pharmacother] 2024 Oct 16. Date of Electronic Publication: 2024 Oct 16.

Importance of hospital and clinical factors for early mortality in Takotsubo syndrome: Insights from the Swedish Coronary Angiography and Angioplasty Registry.

Autor: Gudmundsson T; Department of Cardiology, Department of Molecular and Clinical Medicine, Sahlgrenska University Hospital Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Bruna stråket 16, Gothenburg, 41345, Sweden., Redfors B; Department of Cardiology, Department of Molecular and Clinical Medicine, Sahlgrenska University Hospital Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Bruna stråket 16, Gothenburg, 41345, Sweden., Råmunddal T; Department of Cardiology, Department of Molecular and Clinical Medicine, Sahlgrenska University Hospital Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Bruna stråket 16, Gothenburg, 41345, Sweden., Angerås O; Department of Cardiology, Department of Molecular and Clinical Medicine, Sahlgrenska University Hospital Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Bruna stråket 16, Gothenburg, 41345, Sweden., Petursson P; Department of Cardiology, Department of Molecular and Clinical Medicine, Sahlgrenska University Hospital Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Bruna stråket 16, Gothenburg, 41345, Sweden., Rawshani A; Department of Cardiology, Department of Molecular and Clinical Medicine, Sahlgrenska University Hospital Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Bruna stråket 16, Gothenburg, 41345, Sweden., Hagström H; Department of Cardiology, Umeå University Hospital, Umeå, Sweden., Alfredsson J; Department of Cardiology, University Hospital, Linköping, Sweden., Ekenbäck C; Department of Cardiology, Danderyd University Hospital, Stockholm, Sweden., Henareh L; Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden., Skoglund K; Department of Cardiology, Department of Molecular and Clinical Medicine, Sahlgrenska University Hospital Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Bruna stråket 16, Gothenburg, 41345, Sweden., Ljungman C; Department of Cardiology, Department of Molecular and Clinical Medicine, Sahlgrenska University Hospital Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Bruna stråket 16, Gothenburg, 41345, Sweden., Mohammad M; Department of Cardiology, Skåne University Hospital, Lund, Sweden., Jernberg T; Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden., Fröbert O; Department of Cardiology, Örebro University Hospital, Örebro, Sweden., Erlinge D; Department of Cardiology, Skåne University Hospital, Lund, Sweden., Omerovic E; Department of Cardiology, Department of Molecular and Clinical Medicine, Sahlgrenska University Hospital Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Bruna stråket 16, Gothenburg, 41345, Sweden. elmir@wlab.gu.se.

Publikováno v: BMC cardiovascular disorders [BMC Cardiovasc Disord] 2024 Jul 15; Vol. 24 (1), pp. 359. Date of Electronic Publication: 2024 Jul 15.

Effects of pharmacological interventions on mortality in patients with Takotsubo syndrome: a report from the SWEDEHEART registry.

Autor: Petursson P; Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden., Oštarijaš E; University of Pécs Medical School, Pécs, Hungary., Redfors B; Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden., Råmunddal T; Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden., Angerås O; Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden., Völz S; Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden., Rawshani A; Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden., Hambraeus K; Department of Cardiology, Falun Hospital, Falun, Sweden., Koul S; Department of Cardiology, Skåne University Hospital, Lund, Sweden., Alfredsson J; Department of Cardiology, Linköping University Hospital, Linköping, Sweden., Hagström H; Department of Cardiology, Umeå University Hospital, Umeå, Sweden., Loghman H; Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden., Hofmann R; Department of Cardiology, Södra Hospital, Stockholm, Sweden., Fröbert O; Department of Cardiology, Örebro University Hospital, Örebro, Sweden., Jernberg T; Department of Cardiology, Danderyd University Hospital, Stockholm, Sweden., James S; Department of Cardiology, Uppsala University Hospital, Uppsala, Sweden., Erlinge D; Department of Cardiology, Skåne University Hospital, Lund, Sweden., Omerovic E; Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.

Publikováno v: ESC heart failure [ESC Heart Fail] 2024 Jun; Vol. 11 (3), pp. 1720-1729. Date of Electronic Publication: 2024 Mar 07.

Ten-Year Outcome of Recanalization or Medical Therapy for Concomitant Chronic Total Occlusion After Myocardial Infarction.

Autor: van Veelen A; Department of Cardiology, Heart Center, Amsterdam UMC, Location AMC Amsterdam Cardiovascular Sciences Amsterdam the Netherlands., Coerkamp CF; Department of Cardiology, Heart Center, Amsterdam UMC, Location AMC Amsterdam Cardiovascular Sciences Amsterdam the Netherlands., Somsen YBO; Department of Cardiology, Heart Center, Amsterdam UMC, Location VUMC Amsterdam Cardiovascular Sciences Amsterdam the Netherlands., Råmunddal T; Department of Cardiology Sahlgrenska University Hospital Gothenburg Sweden., Ioanes D; Department of Cardiology Sahlgrenska University Hospital Gothenburg Sweden., Laanmets P; Department of Cardiology North-Estonia Medical Center Tallinn Estonia., van der Schaaf RJ; Department of Cardiology OLVG Hospital Amsterdam the Netherlands., Eriksen E; Department of Cardiology Haukeland University Hospital Bergen Norway., Bax M; Department of Cardiology Haga Teaching Hospital The Hague the Netherlands., Suttorp MJ; Department of Cardiology St. Antonius Hospital Nieuwegein the Netherlands., Strauss BH; Department of Cardiology Sunnybrook Health Sciences Centre Toronto Canada., Barbato E; Department of Clinical and Molecular Medicine Sapienza University of Rome Rome Italy., Marques KM; Department of Cardiology, Heart Center, Amsterdam UMC, Location VUMC Amsterdam Cardiovascular Sciences Amsterdam the Netherlands., Meuwissen M; Department of Cardiology Amphia Hospital Breda the Netherlands., Bertrand O; Department of Cardiology Quebec Heart-Lung Institute Quebec Canada., van der Ent M; Department of Cardiology Maasstad Hospital Rotterdam the Netherlands., Knaapen P; Department of Cardiology, Heart Center, Amsterdam UMC, Location VUMC Amsterdam Cardiovascular Sciences Amsterdam the Netherlands., Tijssen JGP; Department of Cardiology, Heart Center, Amsterdam UMC, Location AMC Amsterdam Cardiovascular Sciences Amsterdam the Netherlands., Claessen BEPM; Department of Cardiology, Heart Center, Amsterdam UMC, Location AMC Amsterdam Cardiovascular Sciences Amsterdam the Netherlands., Hoebers LPC; Department of Cardiology, Heart Center, Amsterdam UMC, Location AMC Amsterdam Cardiovascular Sciences Amsterdam the Netherlands.; Department of Cardiology Maastricht UMC+ Maastricht the Netherlands., Elias J; Department of Cardiology, Heart Center, Amsterdam UMC, Location AMC Amsterdam Cardiovascular Sciences Amsterdam the Netherlands., Henriques JPS; Department of Cardiology, Heart Center, Amsterdam UMC, Location AMC Amsterdam Cardiovascular Sciences Amsterdam the Netherlands.

Publikováno v: Journal of the American Heart Association [J Am Heart Assoc] 2024 May 21; Vol. 13 (10), pp. e033556. Date of Electronic Publication: 2024 May 10.